These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 32962476

  • 1. Haemophilus influenzae type b disease in the era of conjugate vaccines: critical factors for successful eradication.
    Slack M, Esposito S, Haas H, Mihalyi A, Nissen M, Mukherjee P, Harrington L.
    Expert Rev Vaccines; 2020 Oct; 19(10):903-917. PubMed ID: 32962476
    [Abstract] [Full Text] [Related]

  • 2. Haemophilus influenzae type b conjugate vaccines: a review of efficacy data.
    Heath PT.
    Pediatr Infect Dis J; 1998 Sep; 17(9 Suppl):S117-22. PubMed ID: 9781743
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A nationwide population-based surveillance of invasive Haemophilus influenzae diseases in children after the introduction of the Haemophilus influenzae type b vaccine in Japan.
    Suga S, Ishiwada N, Sasaki Y, Akeda H, Nishi J, Okada K, Fujieda M, Oda M, Asada K, Nakano T, Saitoh A, Hosoya M, Togashi T, Matsuoka M, Kimura K, Shibayama K.
    Vaccine; 2018 Sep 11; 36(38):5678-5684. PubMed ID: 30122645
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Hib Vaccines: Their Impact on Haemophilus influenzae Type b Disease.
    Gilsdorf JR.
    J Infect Dis; 2021 Sep 30; 224(12 Suppl 2):S321-S330. PubMed ID: 34590133
    [Abstract] [Full Text] [Related]

  • 8. Haemophilus influenzae meningitis 5 years after introduction of the Haemophilus influenzae type b conjugate vaccine in Brazil.
    Ribeiro GS, Lima JB, Reis JN, Gouveia EL, Cordeiro SM, Lobo TS, Pinheiro RM, Ribeiro CT, Neves AB, Salgado K, Silva HR, Reis MG, Ko AI.
    Vaccine; 2007 May 30; 25(22):4420-8. PubMed ID: 17449150
    [Abstract] [Full Text] [Related]

  • 9. Lot-to-lot consistency, safety and immunogenicity of 3 lots of Haemophilus influenzae type b conjugate vaccine: results from a phase III randomized, multicenter study in infants.
    Klein NP, Abu-Elyazeed R, Cornish M, Leonardi ML, Weiner LB, Silas PE, Grogg SE, Varman M, Frenck RW, Cheuvart B, Baine Y, Miller JM, Leyssen M, Mesaros N, Roy-Ghanta S.
    Vaccine; 2017 Jun 16; 35(28):3564-3574. PubMed ID: 28536030
    [Abstract] [Full Text] [Related]

  • 10. Elimination of Haemophilus influenzae type b (Hib) disease from The Gambia after the introduction of routine immunisation with a Hib conjugate vaccine: a prospective study.
    Adegbola RA, Secka O, Lahai G, Lloyd-Evans N, Njie A, Usen S, Oluwalana C, Obaro S, Weber M, Corrah T, Mulholland K, McAdam K, Greenwood B, Milligan PJ.
    Lancet; 2017 Jun 16; 366(9480):144-50. PubMed ID: 16005337
    [Abstract] [Full Text] [Related]

  • 11. Epidemiology of Haemophilus influenzae type b disease and impact of Haemophilus influenzae type b conjugate vaccines in the United States and Canada.
    Wenger JD.
    Pediatr Infect Dis J; 1998 Sep 16; 17(9 Suppl):S132-6. PubMed ID: 9781746
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.
    Allali S, Chalumeau M, Launay O, Ballas SK, de Montalembert M.
    Cochrane Database Syst Rev; 2018 Aug 20; 8(8):CD011199. PubMed ID: 30125338
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Postlicensure effectiveness of the Haemophilus influenzae type b polysaccharide-Neisseria meningitidis outer-membrane protein complex conjugate vaccine among Navajo children.
    Harrison LH, Tajkowski C, Croll J, Reid R, Hu D, Brenneman G, Weatherholtz RC, Santosham M.
    J Pediatr; 1994 Oct 20; 125(4):571-6. PubMed ID: 7931875
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cost-benefit analysis for the use of Haemophilus influenzae type b conjugate vaccine in Santiago, Chile.
    Levine OS, Ortiz E, Contreras R, Lagos R, Vial P, Misraji A, Ferreccio C, Espinoza C, Adlerstein L, Herrera P.
    Am J Epidemiol; 1993 Jun 01; 137(11):1221-8. PubMed ID: 8322763
    [Abstract] [Full Text] [Related]

  • 18. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom.
    Heath PT, Booy R, Azzopardi HJ, Slack MP, Bowen-Morris J, Griffiths H, Ramsay ME, Deeks JJ, Moxon ER.
    JAMA; 2000 Nov 08; 284(18):2334-40. PubMed ID: 11066183
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Haemophilus influenzae type b disease: impact and effectiveness of diphtheria-tetanus toxoids-acellular pertussis (-inactivated poliovirus)/H. influenzae type b combination vaccines.
    Schmitt HJ, von Kries R, Hassenpflug B, Hermann M, Siedler A, Niessing W, Clemens R, Weil J.
    Pediatr Infect Dis J; 2001 Aug 08; 20(8):767-74. PubMed ID: 11734739
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.